1
/
의
1
Elabscience
SKU(재고 관리 코드):PKSV030433
Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag)
Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag)
Introducing the Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag), a cutting-edge product designed to facilitate advanced research and development in the field of virology. This meticulously engineered recombinant protein offers a highly purified and reliable solution for studying the Spike Receptor Binding Domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag) showcases an innovative A344S mutation, enabling enhanced stability and improved binding affinity. This strategic modification empowers researchers to delve deeper into the intricate mechanisms of viral entry and host cell interaction, unraveling crucial insights into the pathogenesis of COVID-19.
With its His Tag, this recombinant protein ensures facile purification and efficient detection, streamlining experimental workflows and expediting data acquisition. Its exceptional purity, achieved through state-of-the-art production techniques, guarantees minimal interference and maximizes the accuracy of downstream analyses.
The Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag) is meticulously manufactured in compliance with stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Each vial contains a standardized quantity of this invaluable protein, enabling researchers to conduct comprehensive studies with utmost confidence.
This product is intended for use in a wide range of applications, including but not limited to structural biology, drug discovery, vaccine development, and diagnostic assay development. Its versatility and reliability make it an indispensable tool for scientists and researchers striving to combat the ongoing global health crisis.
In summary, the Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag) represents a breakthrough in virological research, offering an exceptional platform for investigating the intricate dynamics of SARS-CoV-2. With its superior stability, enhanced binding affinity, and facile purification, this recombinant protein is poised to revolutionize the understanding and management of COVID-19.
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag) showcases an innovative A344S mutation, enabling enhanced stability and improved binding affinity. This strategic modification empowers researchers to delve deeper into the intricate mechanisms of viral entry and host cell interaction, unraveling crucial insights into the pathogenesis of COVID-19.
With its His Tag, this recombinant protein ensures facile purification and efficient detection, streamlining experimental workflows and expediting data acquisition. Its exceptional purity, achieved through state-of-the-art production techniques, guarantees minimal interference and maximizes the accuracy of downstream analyses.
The Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag) is meticulously manufactured in compliance with stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Each vial contains a standardized quantity of this invaluable protein, enabling researchers to conduct comprehensive studies with utmost confidence.
This product is intended for use in a wide range of applications, including but not limited to structural biology, drug discovery, vaccine development, and diagnostic assay development. Its versatility and reliability make it an indispensable tool for scientists and researchers striving to combat the ongoing global health crisis.
In summary, the Recombinant SARS-CoV-2 Spike RBD(A344S)(His Tag) represents a breakthrough in virological research, offering an exceptional platform for investigating the intricate dynamics of SARS-CoV-2. With its superior stability, enhanced binding affinity, and facile purification, this recombinant protein is poised to revolutionize the understanding and management of COVID-19.
Share
